No, I’m saying future expansion likely had to be prepared for using only Flaskworks and that this required much more apheresis capacity. Neither Advent or NWBO want to spend any more money than absolutely necessary before approval. Both of these issues were dealt with and resolved by Advent. These issues only came to light after the site inspections reportedly done before announcing the change with IFRs to cancer designation from GBM. I don’t believe much in coincidences when money is involved; ). Best wishes.
Market Data 
Markets 
